New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 19, 2012
07:32 EDTHALO, VPHMViroPharma, Halozyme announce initiation of Phase 2b dose to evaluate Cinryze
ViroPharma (VPHM) and Halozyme (HALO) announced that ViroPharma has initiated its Phase 2b double blind, multicenter, dose ranging study to evaluate the safety and efficacy of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology in adolescents and adults with hereditary angioedema for prevention of HAE attacks. This double blind, cross-over, dose ranging study will be conducted in approximately 40 adolescent and adult subjects in the U.S. and Europe. The primary efficacy endpoint is the normalized number of angioedema attacks recorded during each treatment period. In addition, several secondary endpoints will be assessed, including attack severity, quality of life parameters using a novel angioedema tool, and number of angioedema attacks requiring acute treatment.
News For VPHM;HALO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 11, 2014
09:18 EDTHALOHalozyme price target lowered to $10 from $12 at JMP Securities
JMP Securities cut its price target on Halozyme after the company said it intends to explore partnerships and/or strategic alternatives for the Hylenex program in diabetes. The firm removed the diabetes program from its valuation due to uncertainty. It reiterates an Outperform rating on the shares.
November 10, 2014
18:32 EDTHALOOn The Fly: After Hours Movers
Subscribe for More Information
17:26 EDTHALOHalozyme completes workforce reduction
The company noted, "We completed a corporate reorganization to align with strategic priorities. This reorganization resulted in a workforce reduction of 22 employees. We will incur a one-time charge in Q414 that will be largely offset by reduced compensation expenses during the quarter."
16:19 EDTHALOHalozyme reports Q3 EPS (16c), consensus (14c)
Subscribe for More Information
15:26 EDTHALONotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use